42 related articles for article (PubMed ID: 35764097)
1. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.
Barata P; Gulati S; Elliott A; Hammers HJ; Burgess EF; Gartrell BA; Darabi S; Bilen MA; Basu A; Geynisman DM; Dawson NA; Zibelman MR; Zhang T; Wei S; Ryan CJ; Heath EI; Poorman KA; Nabhan C; McKay RR
J Clin Invest; 2024 Apr; ():. PubMed ID: 38652565
[TBL] [Abstract][Full Text] [Related]
3. The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
Hubert JN; Suybeng V; Vallée M; Delhomme TM; Maubec E; Boland A; Bacq D; Deleuze JF; Jouenne F; Brennan P; McKay JD; Avril MF; Bressac-de Paillerets B; Chanudet E
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067022
[No Abstract] [Full Text] [Related]
4. Canadian guideline on genetic screening for hereditary renal cell cancers.
Reaume MN; Graham GE; Tomiak E; Kamel-Reid S; Jewett MA; Bjarnason GA; Blais N; Care M; Drachenberg D; Gedye C; Grant R; Heng DY; Kapoor A; Kollmannsberger C; Lattouf JB; Maher ER; Pause A; Ruether D; Soulieres D; Tanguay S; Turcotte S; Violette PD; Wood L; Basiuk J; Pautler SE;
Can Urol Assoc J; 2013; 7(9-10):319-23. PubMed ID: 24319509
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.
Usui Y; Momozawa Y
Cancer Sci; 2023 Oct; 114(10):3816-3824. PubMed ID: 37530079
[TBL] [Abstract][Full Text] [Related]
7. Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan.
Tamura K; Kanazashi Y; Kawada C; Sekine Y; Maejima K; Ashida S; Karashima T; Kojima S; Parrish NF; Kosugi S; Terao C; Sasagawa S; Fujita M; Johnson TA; Momozawa Y; Inoue K; Shuin T; Nakagawa H
Hum Mol Genet; 2023 Jun; 32(12):2046-2054. PubMed ID: 36905328
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
medRxiv; 2023 Jan; ():. PubMed ID: 36712083
[TBL] [Abstract][Full Text] [Related]
9. Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches.
Ornstein MC; Hutson TE
Cancer J; 2020; 26(5):441-447. PubMed ID: 32947312
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities.
Zarrabi K; Walzer E; Zibelman M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359554
[TBL] [Abstract][Full Text] [Related]
11. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Sekine Y; Iwasaki Y; Aoi T; Endo M; Hirata M; Kamatani Y; Matsuda K; Sugano K; Yoshida T; Murakami Y; Fukui T; Akamatsu S; Ogawa O; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
Hum Mol Genet; 2022 Jun; 31(12):1962-1969. PubMed ID: 35764097
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
[TBL] [Abstract][Full Text] [Related]
13. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
